| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:00–8:00 AM | Breakfast |
| 8:00–8:10 AM | Welcome Remarks |
| 8:10–9:00 AM | Keynote Address |
| Drew Weissman †, University of Pennsylvania Nucleic Acid Approaches to HIV Prevention, Cure, and Equity |
| 9:00–11:15 AM | HIV Vaccines: Clinical Advances |
| Rogier W. Sanders, University of Amsterdam Induction of CD4bs-Directed bNAbs in Humans by Vaccination |
| Douglas S Kwon †, Harvard Medical School Leveraging Mucosal Immunity for HIV Prevention and Cure |
| Penny L Moore †, University of the Witwatersrand and National Institute for Communicable Diseases BRILLIANT Consortium Vaccines for HIV Prevention and Cure |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:15–1:00 PM | Poster Setup |
| 11:15–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 2:30–4:30 PM | Symposia Spotlight 1: Vaccines |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | HIV Vaccines: Pre-Clinical Innovation |
| Neil P King †, University of Washington AI-based Vaccine Design |
| Torben Schiffner †, The Wistar Institute Development of MPER Targeting Vaccines |
| Amelia Escolano †, Wistar Institute Development of V3 Targeting Vaccines |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Posters |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Combination Immunotherapy |
| Lillian B. Cohn †, Fred Hutchinson Cancer Center Immunology of HIV Rebound and Control |
| Elena Vendrame †, Gilead Sciences, Inc Combination immunotherapy approaches at Gilead |
| Steven G Deeks †, University of California, San Francisco CART Cells for HIV Cure |
| Thumbi Ndung'u †, University of KwaZulu-Natal Advances in HIV Cure studies in Africa |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–1:00 PM | Poster Setup |
| 11:00–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 3:00–4:30 PM | Career Roundtable |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | HIV Therapeutic Vaccines |
| Katharine J Bar, University of Pennsylvania Individualized Antibody Vaccines |
| Tariro Makadzange †, Africa Clinical Research Network Clinical trials of Networked Epitope Vaccines for Cure in Africa |
| Beatriz Mothe Pujadas †, IrsiCaixa and Germans Trias i Pujol University Hospital Combination Therapeutic Vaccines |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Posters |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Reservoir Biology |
| Nicolas Chomont †, Université de Montréal Gut Reservoir Biology |
| Michaela Müller-Trutwin †, Institut Pasteur Low-Level NGK2A Expression NK Cells in Non-Pathogenic SIV and as Interventions |
| Valentin Le Douce †, BioNTech SE Strategies for Enhanced Anti-HIV Immunity |
| Xu Yu †, Massachusetts General Hospital Sex Determinants of the Reservoir and Immunity |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–5:00 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: Cures |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–6:45 PM | Cellular and Gene Therapy |
| Mirko Paiardini, Emory University, ENPRC Targeting Negative Regulators of the Immune System for ART-Free HIV Remission |
| Melanie M Ott †, Gladstone Institutes Gene Therapy Approaches to HIV Cure |
| Carl Balibar †, Merck TACK Approaches for Reservoir Reduction |
| Short Talk(s) Chosen from Abstracts |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions |
| 7:00–8:00 PM | Social Hour with Dinner |
| 8:00–11:00 PM | Entertainment |
| 8:00–11:00 PM | Cash Bar |
| 12:00–11:59 PM | Departure |